Results: 1-3 |
Results: 3

Authors: Castagnoli, KP Steyn, SJ Petzer, JP Van der Schyf, CJ Castagnoli, N
Citation: Kp. Castagnoli et al., Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compoundisolated from tobacco, CHEM RES T, 14(5), 2001, pp. 523-527

Authors: Chen, JF Xu, K Petzer, JP Staal, R Xu, YH Beilstein, M Sonsalla, PK Castagnoli, K Castagnoli, N Schwarzschild, MA
Citation: Jf. Chen et al., Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in amodel of Parkinson's disease, J NEUROSC, 21(10), 2001, pp. NIL_1-NIL_6

Authors: Petzer, JP Bergh, JJ Mienie, LJ Castagnoli, N Van der Schyf, CJ
Citation: Jp. Petzer et al., Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats, LIFE SCI, 66(20), 2000, pp. 1949-1954
Risultati: 1-3 |